arrow
J

Joe M. O'Sullivan

queen's university belfast
H指数:63
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

UK real-world data of radium-223 dichloride in metastatic prostate cancer

英国镭-223二氯化物在转移性前列腺癌中的真实世界数据

2025-12-010
PRE
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis

SPARC:标准化前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描分析与报告共识:一项德尔菲分析

2025-09-130
PREAI
The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial

可溶性Fms样酪氨酸激酶1与胎盘生长因子之比可预测疑似子痫前期患者分娩时间和分娩方式:INSPIRE试验的二次分析

2025-03-011
OAAI
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer. the STAMPEDE Phase 3 Randomized Clinical Trial

血浆AR改变及强化激素治疗前列腺癌的时机:STAMPEDE III期随机临床试验

2025-02-270
PRE
Treatment of metastatic castration-resistant prostate cancer: review of current evidence and synthesis of expert opinions on radioligand therapy

转移性去势抵抗性前列腺癌的治疗: 放射性配体治疗的最新证据和专家意见的综述

2025-02-250
OAAI
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus

优化无症状男性前列腺特异性抗原血液检测在初级保健中早期前列腺癌检测的使用: 来自英国临床共识的报告

2024-07-221
OAAI
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer

欧洲核医学协会焦点5: 前列腺癌分子成像和治疗诊断共识

2024-01-018
OA
A Randomized Feasibility Trial of Stereotactic Prostate Radiation Therapy With or Without Elective Nodal Irradiation in High-Risk Localized Prostate Cancer (SPORT Trial)
2023-11-018
OAAI
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

晚期前列腺癌-转移性和/或去势抵抗性前列腺癌患者的管理: 晚期前列腺癌共识会议 (APCCC) 2022的报告

2023-05-0166
OA
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

晚期前列腺癌患者的管理。第一部分: 中/高危和局部晚期疾病,生化复发和激素治疗的副作用: 晚期前列腺癌共识会议2022的报告

2023-03-0164
OA